Laura Pettit

1.7k total citations
20 papers, 123 citations indexed

About

Laura Pettit is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Laura Pettit has authored 20 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Otorhinolaryngology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Laura Pettit's work include Head and Neck Cancer Studies (9 papers), Dysphagia Assessment and Management (4 papers) and Cancer Diagnosis and Treatment (3 papers). Laura Pettit is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Dysphagia Assessment and Management (4 papers) and Cancer Diagnosis and Treatment (3 papers). Laura Pettit collaborates with scholars based in United Kingdom, Austria and Switzerland. Laura Pettit's co-authors include R. Allerton, Paul Sanghera, A. Hartley, J. Glaholm, David J. Berry, Poh Koon Koh, David McGoldrick, Caroline Brammer, Ian Sayers and Megan E. King and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Laura Pettit

19 papers receiving 121 citations

Peers

Laura Pettit

OTORH

SURGE

PRM

ONCOL

RADIA

Gabriele Infante Italy

Parashar J. Nanavati United States

Baomin Zheng China

Jolie Ringash Canada

Shiva Dibaj United States

Shrinivas Rathod Canada

Véronique Buyse Belgium

Karin Stellamans Belgium

Thakshayeni Skanthakumar Singapore

Kurt Geldhof Belgium

Gabriele Infante Italy

Laura Pettit

68 ×1.5

OTORH

47 ×1.3

SURGE

60 ×1.8

PRM

79 ×3.2

ONCOL

5 ×0.2

RADIA

Citations per year, relative to Laura Pettit Laura Pettit (= 1×) peers Gabriele Infante

Countries citing papers authored by Laura Pettit

Since Specialization

Citations

This map shows the geographic impact of Laura Pettit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Pettit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Pettit more than expected).

Fields of papers citing papers by Laura Pettit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Pettit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Pettit. The network helps show where Laura Pettit may publish in the future.

Co-authorship network of co-authors of Laura Pettit

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Pettit. A scholar is included among the top collaborators of Laura Pettit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Pettit. Laura Pettit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verrill, Mark, Laura Pettit, Tamas Hickish, et al.. (2024). A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer. British Journal of Cancer. 130(7). 1149–1156. 1 indexed citations

Verrill, Mark, Laura Pettit, Tamas Hickish, et al.. (2023). Abstract P6-01-11: A UK prospective multicentre decision impact, decision conflict and economic evaluation of the use of Oncotype DX® to guide chemotherapy in 680 women with hormone receptor positive, HER2 negative breast cancer and 1 to 3 nodes involved. Cancer Research. 83(5_Supplement). P6–1. 1 indexed citations

Pettit, Laura, et al.. (2022). Severe hyponatraemia in two patients with breast cancer caused by low-dose cyclophosphamide and precipitated by aprepitant. BMJ Case Reports. 15(3). e248408–e248408. 2 indexed citations

Nutting, Christopher M., Keith Rooney, Bernadette Foran, et al.. (2022). Quality of life and two-year results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (DO-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.. Journal of Clinical Oncology. 40(16_suppl). 6065–6065. 2 indexed citations

McGoldrick, David, et al.. (2021). Masseter muscle defined sarcopenia and survival in head and neck cancer patients. British Journal of Oral and Maxillofacial Surgery. 60(4). 454–458. 10 indexed citations

Nutting, Christopher M., Keith Rooney, Bernadette Foran, et al.. (2020). Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.. Journal of Clinical Oncology. 38(15_suppl). 6508–6508. 23 indexed citations

Thomas, Daniel L., Caroline Archer, Anne Rigg, et al.. (2020). Abstract OT3-17-03: Impact of the Oncotype DX breast cancer assay on treatment decisions in a UK population of patients with oestrogen receptor positive early breast cancer with 1-3 lymph nodes positive who are candidates for chemotherapy, but for whom the benefits are uncertain - Interim results. Cancer Research. 80(4_Supplement). OT3–17. 3 indexed citations

McGoldrick, David, et al.. (2020). Masseter muscle defined sarcopenia and survival in head and neck cancer patients at a single cancer centre. British Journal of Oral and Maxillofacial Surgery. 58(10). e157–e158. 1 indexed citations

Fussey, Jonathan, et al.. (2017). Thyroid‐stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach. Head & Neck. 39(12). 2567–2572. 2 indexed citations

10.

Allerton, R., et al.. (2016). The impact of the introduction of a palliative Macmillan consultant radiographer at one UK cancer centre. British Journal of Radiology. 89(1065). 20160286–20160286. 9 indexed citations

11.

Allerton, R., et al.. (2015). Hormone Therapy for Breast Cancer in Men. Clinical Breast Cancer. 15(4). 245–250. 15 indexed citations

12.

Brammer, Caroline, Laura Pettit, R. Allerton, et al.. (2014). Impact of the introduction of weekly radiotherapy quality assurance meetings at one UK cancer centre. British Journal of Radiology. 87(1043). 20140422–20140422. 13 indexed citations

13.

Pettit, Laura, et al.. (2014). Panoramic Radiobiological Modelling of the Contribution of Concomitant Chemotherapy to Biological Effective Dose in Squamous Cell Carcinoma. 3(1). 5 indexed citations

14.

Pettit, Laura, et al.. (2013). Radical Chemoradiotherapy for Urethral Squamous Cell Carcinoma: Two Case Reports and a Review of the Literature. SHILAP Revista de lepidopterología. 2013. 1–4. 4 indexed citations

15.

Pettit, Laura, Paul Sanghera, J. Glaholm, & A. Hartley. (2013). The use of MuGard™, Caphosol^®and Episil^®in patients undergoing chemoradiotherapy for squamous cell carcinoma of the head and neck. Journal of Radiotherapy in Practice. 13(2). 218–225. 6 indexed citations

16.

Pettit, Laura, Susanna Meade, Paul Sanghera, et al.. (2012). Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation?. British Journal of Radiology. 86(1021). 20120372–20120372. 7 indexed citations

17.

Pettit, Laura, et al.. (2011). THE USE OF MUGARD(TM) AND CAPHOSOL(R) IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK. Radiotherapy and Oncology. 98. S25–S25. 1 indexed citations

18.

Pettit, Laura, et al.. (2011). Use of Mugard™ and CaphosolR in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical Oncology. 23(3). S48–S48. 2 indexed citations

19.

Pettit, Laura, et al.. (2010). The role of somatostatin analogues in the treatment of advanced malignant thymomas: case report and review of the literature. British Journal of Radiology. 84(997). e7–e10. 10 indexed citations

20.

Berry, David J., et al.. (1986). Phenylethylmalonamide Serum Levels in Patients Treated with Primidone and the Effects of Other Antiepileptic Drugs. Therapeutic Drug Monitoring. 8(2). 161–165. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact